- New Cystic Fibrosis Drug — WVU Health Report
- DEA Targets Gas Station, Jeweler in 29-State Synthetic Drug Sweep – Los Angeles Times
- News in Brief: ADA Father of the Year Awards Announced
- Elk County Jail Experiences Overcrowding
- Are There Any Doctors in Michigan Who Prescribe Methadone for Addiction?
- Defibrillator After Heart Attack? What Does That Mean?
- Residential Psychiatric Treatment for Young Adults in New England?
- Addiction Treatment Center
- Prescription Drug Abuse a Problem – San Angelo Standard Times
- Drug Rehab Centers Howard County Call 410-777-5692 for Help Now MD
- Who’s Know About Drug Addiction?
- Addiction in the Heartland, How Drugs and Alcohol Are Poisoning Our Youth
- Prescription Drug Abuse a Problem – San Angelo Standard Times
Gabapentin Gets a Boost in Treating Alcoholism
Gabapentin Gets A Boost In Treating Alcoholism
Filed under: drug abuse treatment outcome study
Barbara J. Mason, Ph.D., Pearson Family Chair, Professor and Director, Laboratory of Clinical Psychopharmacology, and Co-Director, Pearson Center for Alcoholism and Addiction Research. … At 12 weeks, only 4.1% of subjects receiving placebo reported …
Read more on Forbes
Dachel Media Review: J & J Fine, Autism Risk
Filed under: drug abuse treatment outcome study
"In addition, Janssen also allegedly promoted the antipsychotic drug for use in children and individuals with mental disabilities, to treat disorders ranging from attention deficit hyperactivity disorder to autism, even though it had not been approved …
Read more on Age of Autism
Why the true burden of paediatric TB remains unknown
Filed under: drug abuse treatment outcome study
After years of neglect, WHO in its recent report — Road map for childhood tuberculosis — has rightly pointed out saying: “the urgency of the problem of TB in children, whose full scope is still not fully known, cannot be underestimated.” In 2012, the …
Read more on The Hindu
Furiex Pharmaceuticals Inc (FURX): Furiex Pharmaceuticals Management …
Filed under: drug abuse treatment outcome study
As you know, this is a novel, oral, locally active new agonist delta antagonist that's in development for treatment of diarrhea-predominant irritable bowel syndrome, or IBS-D. We believe that the dual activity on both mu and delta opiate receptors …
Read more on Seeking Alpha